Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000822333 | SCV000963131 | pathogenic | not provided | 2022-12-28 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 664269). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with DDX41-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu122*) in the DDX41 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DDX41 are known to be pathogenic (PMID: 26712909, 27133828). |
Mendelics | RCV002249532 | SCV002519086 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003467511 | SCV004190956 | likely pathogenic | DDX41-related hematologic malignancy predisposition syndrome | 2023-09-08 | criteria provided, single submitter | clinical testing |